Vasodilator and hypotensive effects of the optical isomers of nicardipine (YC-93),a new Ca2+-antagonist.
Open Access
- 1 January 1982
- journal article
- research article
- Published by Elsevier in The Japanese Journal of Pharmacology
- Vol. 32 (4) , 665-670
- https://doi.org/10.1254/jjp.32.665
Abstract
Vasodilator and hypotensive effects of (+) and (-) nicardipine were investigated in anesthetized dogs. When administered intravenously, (+) nicardipine was 3 times as potent as the (-) isomer in increasing vertebral blood flow and in lowering mean blood pressure. When injected into the vertebral artery, (+) nicardipine was also 3 times as potent as the (-) isomer in increasing vertebral blood flow. Upon both routes of administration, the duration of the action after (+) nicardipine was longer than that after the (-) isomer. However, there were no differences of plasma nicardipine levels after intravenous injection of both isomers to conscious beagle dogs. The LD50 values of (+) nicardipine in mice and rats upon intravenous injection were only 1.5-2 times smaller than those of the (-) isomer. These results indicate that there exists a stereoselectivity of vasodilator and hypotensive actions among the nicardipine isomers.This publication has 5 references indexed in Scilit:
- Inhibition of calcium influx in rabbit aorta by nicardipine hydrochloride (YC-93)Biochemical Pharmacology, 1981
- A possible mechanism for relaxation of rat uterine smooth muscle by nicardipine hydrochloride (YC-93), a new potent vasodilator.The Japanese Journal of Pharmacology, 1981
- Synthesis of optically active 2-(N-benzyl-N-methylamino)ethyl methyl 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate (nicardipine).CHEMICAL & PHARMACEUTICAL BULLETIN, 1980
- CEREBROVASCULAR EFFECTS OF YC-93, A NEW VASODILATOR, IN DOGS, MONKEYS AND HUMAN PATIENTS1979
- A SIMPLIFIED METHOD OF EVALUATING DOSE-EFFECT EXPERIMENTS1949